It is a pharma public limited company based in Delhi, Delhi, India, established in 2021.
2021 | Delhi, Delhi, India | ActiveMedilia Limited, a active public limited company, was established on 03 June 2021 in Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24299DL2021PLC381855. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹12.00 Cr and a paid-up capital of ₹3.00 Cr.
Its leadership includes Harish Goyal (Director), Pratik Pramod Gupta (Director), Gaurav Rajput (Director). Past directors included Vipul Singal, Shubham Goyal, Pratik Pramod Gupta. It holds ₹99.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.37, Ground Floor, Pocket N Sector-5, Bawana Dsidc, Delhi, Delhi, 110039.
U24299DL2021PLC381855
381855
03 June 2021
₹12.00 Cr
₹3.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Medilia Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harish Goyal | Director | 03 Jun 2021 | Current |
| Pratik Pramod Gupta | Director | 01 Apr 2024 | Current |
| Gaurav Rajput | Director | 08 Dec 2021 | Current |
| Anant Aggarwal | Director | 08 Dec 2021 | Current |
| Amarjyot Singh Anand | Director | 01 Apr 2024 | Current |
| Akshay Pramod Gupta | Director | 01 Jun 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Dec 2021 | Past |
| Pramod Abcsdd | Director | 09 Dec 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Nov 2024 | Past |
| Pramod Abcsdd | Additional Director | 31 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 31 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Nov 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medilia Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 52.78% decrease. The company also saw a substantial improvement in profitability, with a 44.44% increase in profit. The company's net worth dipped by a decrease of 1.81%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Medilia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹990,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jul 2024 | Axis Bank Limited | ₹99.00 Cr | Open |
Explore comprehensive loan charge details -
Medilia has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Medilia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medilia's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kayan Sharma was appointed as a Additional Director was appointed as a Additional Director on 12 Sep 2025 & has been associated with this company since 2 months 19 days . was completed.
The activity A charge with Axis Bank Limited of Rs. 99.00 Cr registered on 02 Jul 2024 with Charge ID 100960163 was modified on 28 Dec 2024. was completed.
Progress on Medilia Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge with Axis Bank Limited amounted to Rs. 99.00 Cr with Charge ID 100960163 was registered on 02 Jul 2024. was recorded as a recent event.
Progress on Akshay Pramod Gupta was appointed as a Director was appointed as a Director on 01 Jun 2024 & has been associated with this company since 1 year 6 months . was documented.
The activity Pratik Pramod Gupta was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 1 year 7 months . was completed.
The CIN of Medilia Limited is U24299DL2021PLC381855.
Medilia Limited is headquartered at Plot No.37, Ground Floor, Pocket N Sector-5, Bawana Dsidc, Delhi, Delhi, 110039.
Medilia Limited was incorporated on 03 June 2021.
The current directors of Medilia Limited are
The primary industry of Medilia Limited is Pharma.
Medilia Limited is unlisted.
The authorized capital of Medilia Limited is ₹12.00 Cr, and the paid-up capital is ₹3.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX